Perceptive Advisors LLC decreased its holdings in Singular Genomics Systems, Inc. (NASDAQ:OMIC – Free Report) by 96.7% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 70,896 shares of the company’s stock after selling 2,055,997 shares during the quarter. Perceptive Advisors LLC owned about 2.87% of Singular Genomics Systems worth $599,000 as of its most recent filing with the Securities & Exchange Commission.
Analyst Upgrades and Downgrades
Separately, The Goldman Sachs Group reduced their target price on Singular Genomics Systems from $22.50 to $6.50 and set a “neutral” rating on the stock in a report on Tuesday, July 9th.
Read Our Latest Research Report on OMIC
Singular Genomics Systems Stock Down 0.1 %
Singular Genomics Systems (NASDAQ:OMIC – Get Free Report) last announced its earnings results on Tuesday, August 13th. The company reported ($8.57) earnings per share for the quarter, beating analysts’ consensus estimates of ($8.86) by $0.29. Singular Genomics Systems had a negative net margin of 3,375.72% and a negative return on equity of 54.66%. The business had revenue of $0.74 million during the quarter, compared to the consensus estimate of $0.40 million.
About Singular Genomics Systems
Singular Genomics Systems, Inc, a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables for applications comprising single cell gene expression and proteomics, in situ RNA sequencing, and spatial RNA and proteomics applications for tissue.
See Also
- Five stocks we like better than Singular Genomics Systems
- ETF Screener: Uses and Step-by-Step Guide
- Top 5 ETFs to Own Now and Into 2025
- Airline Stocks – Top Airline Stocks to Buy Now
- Watch These 3 Former Short-Squeeze Stocks for a Big Rally
- How to Invest in Blue Chip Stocks
- Simon Property REIT: A Safe Bet for Growth and Steady Dividends
Want to see what other hedge funds are holding OMIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Singular Genomics Systems, Inc. (NASDAQ:OMIC – Free Report).
Receive News & Ratings for Singular Genomics Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Singular Genomics Systems and related companies with MarketBeat.com's FREE daily email newsletter.